I’m reminded again Dr Jay Lalezari’s suggestion (concerning multiple indications) that Leronlimab needs to be “Stockpiled.”

Ohm said,
“I would not doubt that we get prepaid for further production just so entities can lock in delivery.”

Well...yes. I concur FWIW.